233 related articles for article (PubMed ID: 8411353)
1. Incorporation of human immunodeficiency virus type 1 Gag proteins into murine leukemia virus virions.
Deminie CA; Emerman M
J Virol; 1993 Nov; 67(11):6499-506. PubMed ID: 8411353
[TBL] [Abstract][Full Text] [Related]
2. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo.
Berkowitz RD; Ohagen A; Höglund S; Goff SP
J Virol; 1995 Oct; 69(10):6445-56. PubMed ID: 7666546
[TBL] [Abstract][Full Text] [Related]
3. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation.
Zhang Y; Barklis E
J Virol; 1995 Sep; 69(9):5716-22. PubMed ID: 7637017
[TBL] [Abstract][Full Text] [Related]
4. Functional exchange of an oncoretrovirus and a lentivirus matrix protein.
Deminie CA; Emerman M
J Virol; 1994 Jul; 68(7):4442-9. PubMed ID: 8207817
[TBL] [Abstract][Full Text] [Related]
5. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.
Lee PP; Linial ML
J Virol; 1994 Oct; 68(10):6644-54. PubMed ID: 7521919
[TBL] [Abstract][Full Text] [Related]
6. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.
Cimarelli A; Luban J
J Virol; 1999 Jul; 73(7):5388-401. PubMed ID: 10364286
[TBL] [Abstract][Full Text] [Related]
7. The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811.
Dorfman T; Göttlinger HG
J Virol; 1996 Sep; 70(9):5751-7. PubMed ID: 8709190
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of Pr160(gag-pol) into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein.
Huang M; Martin MA
J Virol; 1997 Jun; 71(6):4472-8. PubMed ID: 9151838
[TBL] [Abstract][Full Text] [Related]
10. Bovine leukemia virus Gag particle assembly in insect cells: formation of chimeric particles by domain-switched leukemia/lentivirus Gag polyprotein.
Kakker NK; Mikhailov MV; Nermut MV; Burny A; Roy P
Virology; 1999 Dec; 265(2):308-18. PubMed ID: 10600602
[TBL] [Abstract][Full Text] [Related]
11. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.
Yu X; Yuan X; Matsuda Z; Lee TH; Essex M
J Virol; 1992 Aug; 66(8):4966-71. PubMed ID: 1629961
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus.
Ott DE; Coren LV; Copeland TD; Kane BP; Johnson DG; Sowder RC; Yoshinaka Y; Oroszlan S; Arthur LO; Henderson LE
J Virol; 1998 Apr; 72(4):2962-8. PubMed ID: 9525617
[TBL] [Abstract][Full Text] [Related]
13. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.
Poon DT; Li G; Aldovini A
J Virol; 1998 Mar; 72(3):1983-93. PubMed ID: 9499052
[TBL] [Abstract][Full Text] [Related]
14. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins.
Bennett RP; Nelle TD; Wills JW
J Virol; 1993 Nov; 67(11):6487-98. PubMed ID: 8411352
[TBL] [Abstract][Full Text] [Related]
15. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
Kondo E; Mammano F; Cohen EA; Göttlinger HG
J Virol; 1995 May; 69(5):2759-64. PubMed ID: 7707498
[TBL] [Abstract][Full Text] [Related]
16. The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivo.
Yu Q; Darlix JL
J Virol; 1996 Sep; 70(9):5791-8. PubMed ID: 8709195
[TBL] [Abstract][Full Text] [Related]
17. Targeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication.
Natsoulis G; Seshaiah P; Federspiel MJ; Rein A; Hughes SH; Boeke JD
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):364-8. PubMed ID: 7831291
[TBL] [Abstract][Full Text] [Related]
18. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
[TBL] [Abstract][Full Text] [Related]
19. Murine leukemia virus particle assembly quantitated by fluorescence microscopy: role of Gag-Gag interactions and membrane association.
Andrawiss M; Takeuchi Y; Hewlett L; Collins M
J Virol; 2003 Nov; 77(21):11651-60. PubMed ID: 14557651
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of viral assembly in murine cells by HIV-1 matrix.
Hübner W; Chen BK
Virology; 2006 Aug; 352(1):27-38. PubMed ID: 16750235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
